Bulk Drug Wholesale Licence: India Drafts Separate Permit for API Traders
India has proposed a separate wholesale licence for bulk drugs and APIs, with new Forms 19-BC and 20-BC, NDPS coverage and a 30-day comment window. What changes for traders.
India has proposed a separate wholesale licence for bulk drugs and APIs, with new Forms 19-BC and 20-BC, NDPS coverage and a 30-day comment window. What changes for traders.